Ignite Creation Date:
2024-05-05 @ 5:06 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00385606
Status:
COMPLETED
Last Update Posted:
2023-03-23
First Post:
2006-10-10
Brief Title:
Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced NSCLC
Sponsor:
National Cancer Institute Naples
Organization:
National Cancer Institute Naples
Organization Data
Organization:
National Cancer Institute Naples
Class:
OTHER
Study ID:
GECO
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
National Cancer Institute Naples
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None